Evidence map›Paper›PMID 20046221›Full record

ArticleJournal of innate immunity2009

Anthrax edema toxin inhibits Nox1-mediated formation of reactive oxygen species by colon epithelial cells.

Jun-Sub Kim, Gary M Bokoch

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jun-Sub KimDepartment of Immunology, Scripps Research Institute, La Jolla, Calif., USA.
Gary M Bokoch
Scripps Research Institute · US

Funding

G PROTEIN REGULATION OF THE NEUTROPHIL NADPH OXIDASER01HL048008 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI DERMARDIROSSIAN, CELINE · 1991 to 2010
$5.7M
Regulation of the Innate Immune Response to B AnthracisP01CI000095 · CI · SCRIPPS RESEARCH INSTITUTE, THE · PI BOKOCH, GARY M · 2003 to 2007
$4.0M
NCPDCID CDC HHS CI000095NCPDCID CDC HHS P01 CI000095NHLBI NIH HHS HL48008NHLBI NIH HHS R01 HL048008
6 · The paper itself

Abstract

One major route of intoxication by Bacillus anthracis (anthrax) spores is via their ingestion and subsequent uptake by the intestinal epithelium. Anthrax edema toxin (ETx) is an adenylate cyclase that causes persistent elevation of cAMP in intoxicated cells. NADPH oxidase enzymes (Nox1-Nox5, Duox1 and 2) generate reactive oxygen species (ROS) as components of the host innate immune response to bacteria, including Nox1 in gastrointestinal epithelial tissues. We show that ETx effectively inhibits ROS formation by Nox1 in HT-29 colon epithelial cells. This inhibition requires the PKA-mediated phosphorylation of the Nox1-regulatory component, NoxA1, and the subsequent binding of 14-3-3zeta. Inhibition of Nox1-mediated ROS formation in the gut epithelium may be a mechanism used by B. anthracis to circumvent the innate immune response.

Indexed as

AnthraxAntigens, BacterialBacillus anthracisBacterial ToxinsCell Line, TumorColonDown-RegulationHost-Pathogen InteractionsHumansImmunity, InnateIntestinal MucosaNADPH Oxidase 1NADPH OxidasesReactive Oxygen Speciesanthrax toxinAntigens, BacterialBacterial ToxinsNADPH Oxidase 1NADPH OxidasesNOX1 protein, humanReactive Oxygen Species14-3-3 proteinsAnthraxcAMP-dependent protein kinasecolon epitheliumedema toxininnate immunityNADPH oxidasephosphorylationprotein kinase Areactive oxygen species

Identifiers

PMID20046221
PMCPMC2631933
OpenAlexW1982730511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.